Business Description
Imagion Biosystems Ltd
ISIN : AU000000IBX6
Description
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer. The company operates in Australia and the USA, with revenue from Australia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | -1.06 | |||||
Debt-to-Equity | -1.19 | |||||
Debt-to-EBITDA | -0.74 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 66.2 | |||||
3-Year EPS without NRI Growth Rate | 64.2 | |||||
3-Year FCF Growth Rate | 63.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.82 | |||||
14-Day RSI | 98.92 | |||||
3-1 Month Momentum % | 167.86 | |||||
6-1 Month Momentum % | 200 | |||||
12-1 Month Momentum % | 275 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.48 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -159.1 | |||||
Shareholder Yield % | -54.54 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -223.65 | |||||
ROIC % | -121.11 | |||||
3-Year ROIIC % | -241.25 | |||||
ROC (Joel Greenblatt) % | -26653.85 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -1.92 | |||||
EV-to-EBITDA | -1.93 | |||||
EV-to-FCF | -1.65 | |||||
Price-to-GF-Value | 0.27 | |||||
Earnings Yield (Greenblatt) % | -52.08 | |||||
FCF Yield % | -68.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IBXXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Imagion Biosystems Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.01 | ||
| Beta | 5.7091 | ||
| 3-Year Sharpe Ratio | 0.61 | ||
| 3-Year Sortino Ratio | 2.02 | ||
| Volatility % | 234.88 | ||
| 14-Day RSI | 98.92 | ||
| 14-Day ATR ($) | 0.000291 | ||
| 20-Day SMA ($) | 0.03 | ||
| 12-1 Month Momentum % | 275 | ||
| 52-Week Range ($) | 0.008 - 0.04 | ||
| Shares Outstanding (Mil) | 539.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Imagion Biosystems Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Imagion Biosystems Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2024 | 2025-05-09 | 0.01 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-04-30 | 0.01 (+0.00%) | ||
| Fourth quarter earnings results for 2024 | 2025-01-31 | 0.04 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-10-30 | 0.04 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-07-31 | 0.04 (+0.00%) | ||
| 0.025:1 Stock Split | 2023-11-16 | 0.96 (+0.00%) |
Show
Entries
Imagion Biosystems Ltd Frequently Asked Questions
What is Imagion Biosystems Ltd(IBXXF)'s stock price today?
The current price of IBXXF is $0.03. The 52 week high of IBXXF is $0.04 and 52 week low is $0.01.
When is next earnings date of Imagion Biosystems Ltd(IBXXF)?
The next earnings date of Imagion Biosystems Ltd(IBXXF) is .
Does Imagion Biosystems Ltd(IBXXF) pay dividends? If so, how much?
Imagion Biosystems Ltd(IBXXF) does not pay dividend.
Guru Commentaries on OTCPK:IBXXF
No articles.
Press Release
Articles on Imagion Biosystems Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers